Cargando…

Cross-Cultural Validation of the 5-Item Compliance Questionnaire for Rheumatology to the Arabic Language in Patients with Rheumatoid Arthritis

PURPOSE: A simple measure to assess drug adherence in Saudi patients with rheumatoid arthritis (RA) is required. The aim of this study was to translate and validate the 5-Item Compliance Questionnaire for Rheumatology (CQR5) into Arabic. PATIENTS AND METHODS: The questionnaire was translated and cul...

Descripción completa

Detalles Bibliográficos
Autores principales: Omair, Mohammed A, Al Suwayeh, Fatima, Almashaan, Alanoud, Alqurtas, Eman, Bedaiwi, Mohammed K, Almaghlouth, Ibrahim, Alkahalaf, Abdulaziz, Almalaq, Haya M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253897/
https://www.ncbi.nlm.nih.gov/pubmed/34234419
http://dx.doi.org/10.2147/PPA.S316263
_version_ 1783717613801570304
author Omair, Mohammed A
Al Suwayeh, Fatima
Almashaan, Alanoud
Alqurtas, Eman
Bedaiwi, Mohammed K
Almaghlouth, Ibrahim
Alkahalaf, Abdulaziz
Almalaq, Haya M
author_facet Omair, Mohammed A
Al Suwayeh, Fatima
Almashaan, Alanoud
Alqurtas, Eman
Bedaiwi, Mohammed K
Almaghlouth, Ibrahim
Alkahalaf, Abdulaziz
Almalaq, Haya M
author_sort Omair, Mohammed A
collection PubMed
description PURPOSE: A simple measure to assess drug adherence in Saudi patients with rheumatoid arthritis (RA) is required. The aim of this study was to translate and validate the 5-Item Compliance Questionnaire for Rheumatology (CQR5) into Arabic. PATIENTS AND METHODS: The questionnaire was translated and culturally adapted to Arab patients in six steps: initial translation, synthesis of the translation, back translation, expert committee review, test of the pre-final version, and development of the Arabic CQR5 (ACQR-5). The resulting version was tested for validity in patients with RA. RESULTS: A total of 103 adult patients with RA were recruited from rheumatology clinics at a university hospital in Riyadh, Saudi Arabia. After extensive translation, the final tool (CQR) was piloted in 15 patients. The final validation was performed with 88 patients. Of these, 80 (90.9%) were female and 43.2% were seropositive. The mean (±SD) age and disease duration were 50 (±13) and 11.4 (±8.2) years, respectively. Cronbach’s alpha reliability was 0.886, and the Kaiser-Meyer-Olkin measure of sampling adequacy for factor analysis was 0.870 (p<0.001). The mean ACQR-5 was 17.78 (2.70), with 14 (15.9%) classified as low adherents and the remaining 74 (84.1%) as high adherents. Binary logistic regression revealed that increasing age (odds ratio [OR] 1.082, 95% confidence interval [CI]: 1.025–1.142, p=0.005) and a trend toward the presence of other comorbidities (OR 3.111, 95% CI: 0.961–10.070, p=0.058) were associated with low adherence. CONCLUSION: ACQR-5 is a simple and feasible tool for identifying adherence levels in patients with RA in Saudi Arabia. A high level of adherence was observed in this study. Additional studies are required to assess ACQR-5 validity and adherence levels in a larger, more diverse population.
format Online
Article
Text
id pubmed-8253897
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82538972021-07-06 Cross-Cultural Validation of the 5-Item Compliance Questionnaire for Rheumatology to the Arabic Language in Patients with Rheumatoid Arthritis Omair, Mohammed A Al Suwayeh, Fatima Almashaan, Alanoud Alqurtas, Eman Bedaiwi, Mohammed K Almaghlouth, Ibrahim Alkahalaf, Abdulaziz Almalaq, Haya M Patient Prefer Adherence Original Research PURPOSE: A simple measure to assess drug adherence in Saudi patients with rheumatoid arthritis (RA) is required. The aim of this study was to translate and validate the 5-Item Compliance Questionnaire for Rheumatology (CQR5) into Arabic. PATIENTS AND METHODS: The questionnaire was translated and culturally adapted to Arab patients in six steps: initial translation, synthesis of the translation, back translation, expert committee review, test of the pre-final version, and development of the Arabic CQR5 (ACQR-5). The resulting version was tested for validity in patients with RA. RESULTS: A total of 103 adult patients with RA were recruited from rheumatology clinics at a university hospital in Riyadh, Saudi Arabia. After extensive translation, the final tool (CQR) was piloted in 15 patients. The final validation was performed with 88 patients. Of these, 80 (90.9%) were female and 43.2% were seropositive. The mean (±SD) age and disease duration were 50 (±13) and 11.4 (±8.2) years, respectively. Cronbach’s alpha reliability was 0.886, and the Kaiser-Meyer-Olkin measure of sampling adequacy for factor analysis was 0.870 (p<0.001). The mean ACQR-5 was 17.78 (2.70), with 14 (15.9%) classified as low adherents and the remaining 74 (84.1%) as high adherents. Binary logistic regression revealed that increasing age (odds ratio [OR] 1.082, 95% confidence interval [CI]: 1.025–1.142, p=0.005) and a trend toward the presence of other comorbidities (OR 3.111, 95% CI: 0.961–10.070, p=0.058) were associated with low adherence. CONCLUSION: ACQR-5 is a simple and feasible tool for identifying adherence levels in patients with RA in Saudi Arabia. A high level of adherence was observed in this study. Additional studies are required to assess ACQR-5 validity and adherence levels in a larger, more diverse population. Dove 2021-06-28 /pmc/articles/PMC8253897/ /pubmed/34234419 http://dx.doi.org/10.2147/PPA.S316263 Text en © 2021 Omair et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Omair, Mohammed A
Al Suwayeh, Fatima
Almashaan, Alanoud
Alqurtas, Eman
Bedaiwi, Mohammed K
Almaghlouth, Ibrahim
Alkahalaf, Abdulaziz
Almalaq, Haya M
Cross-Cultural Validation of the 5-Item Compliance Questionnaire for Rheumatology to the Arabic Language in Patients with Rheumatoid Arthritis
title Cross-Cultural Validation of the 5-Item Compliance Questionnaire for Rheumatology to the Arabic Language in Patients with Rheumatoid Arthritis
title_full Cross-Cultural Validation of the 5-Item Compliance Questionnaire for Rheumatology to the Arabic Language in Patients with Rheumatoid Arthritis
title_fullStr Cross-Cultural Validation of the 5-Item Compliance Questionnaire for Rheumatology to the Arabic Language in Patients with Rheumatoid Arthritis
title_full_unstemmed Cross-Cultural Validation of the 5-Item Compliance Questionnaire for Rheumatology to the Arabic Language in Patients with Rheumatoid Arthritis
title_short Cross-Cultural Validation of the 5-Item Compliance Questionnaire for Rheumatology to the Arabic Language in Patients with Rheumatoid Arthritis
title_sort cross-cultural validation of the 5-item compliance questionnaire for rheumatology to the arabic language in patients with rheumatoid arthritis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253897/
https://www.ncbi.nlm.nih.gov/pubmed/34234419
http://dx.doi.org/10.2147/PPA.S316263
work_keys_str_mv AT omairmohammeda crossculturalvalidationofthe5itemcompliancequestionnaireforrheumatologytothearabiclanguageinpatientswithrheumatoidarthritis
AT alsuwayehfatima crossculturalvalidationofthe5itemcompliancequestionnaireforrheumatologytothearabiclanguageinpatientswithrheumatoidarthritis
AT almashaanalanoud crossculturalvalidationofthe5itemcompliancequestionnaireforrheumatologytothearabiclanguageinpatientswithrheumatoidarthritis
AT alqurtaseman crossculturalvalidationofthe5itemcompliancequestionnaireforrheumatologytothearabiclanguageinpatientswithrheumatoidarthritis
AT bedaiwimohammedk crossculturalvalidationofthe5itemcompliancequestionnaireforrheumatologytothearabiclanguageinpatientswithrheumatoidarthritis
AT almaghlouthibrahim crossculturalvalidationofthe5itemcompliancequestionnaireforrheumatologytothearabiclanguageinpatientswithrheumatoidarthritis
AT alkahalafabdulaziz crossculturalvalidationofthe5itemcompliancequestionnaireforrheumatologytothearabiclanguageinpatientswithrheumatoidarthritis
AT almalaqhayam crossculturalvalidationofthe5itemcompliancequestionnaireforrheumatologytothearabiclanguageinpatientswithrheumatoidarthritis